사이트 바로가기
뉴스
- Sky's the limit — but not for spaces: The best spots to watch the Seoul... the 2026 Seoul International Fireworks Festival. The main view for the early birds Yeouido Hangang Park remains the top and most obvious spot, with the stretch
- Curiox Hits Limit-Up; CPS Overhang Weighs on OliX[K-Bio Pulse] On Aug. 14, Curiox Biosystems hit the daily upper limit after announcing a “multi-unit” order
- Kolon TissueGene Escapes Fourth Limit-Down; Peptron Jumps After Hours[K-Bio Pulse] Kolon TissueGene narrowly avoided a fourth consecutive limit-down close, while Peptron surged in after-hours
- FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls... FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock split...
- i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse] South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting second quarter earnings that far exceeded market exp
- Deepnoid and Peptron Hit Daily Limit, L&C Bio Falls on Rights Offering[K-Bio Pulse] South Korea's pharmaceutical and biotechnology sector received a boost on Aug. 3 as the KOSDAQ market posted strong gains. Buying momentum intensified, triggeri
- Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended
- BL Pharmtech Hits Daily Limit…Samchundang Pharm Falls[K-bio pulse] continued to show strong interest in BL Pharmtech on July 2, driving its stock to the daily upper limit
- HLB Hits Limit-Up on FDA Optimism; Curiosis, Peptron Rebound Sharply [K-Bio Pulse] On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates, while Curiosis and Peptron posted double-digit gains
- Lemon Healthcare Rebounds to Limit-Up on Second Trading Day; D&D Pharmatech, PharmaResearch Also ... South Korea's pharmaceutical and biotech sector posted broad gains on Tuesday despite heightened market volatility that triggered a sell-side sidecar on the ben
1 페이지
다음 →